Summary of Research on Prodovite® (VMP35)*



2015

The effect of VMP35 supplement ingredients encapsulated in a novel Phospholipid Prodosome SK713 SLP nutrient delivery technology observed as a result of changes in properties of live human blood.

B. William Downs, Steven Kushner, Ted Aloisio, Frans J. Cronjé and Kenneth Blum

Functional Foods in Health and Disease. 2015; 5(9): 292-303


Abstract:

Background: In North America digestive malfunction in terms of disintegration, dissolution, and absorption of food and nutrients, is a widespread malady. Malabsorption is also an exacerbating factor in most chronic degenerative diseases that might benefit from dietary supplementation. The purpose of this experiment was to evaluate absorption following the sublingual administration of VMP35 SK713 encapsulated nutraceutical formulation.

Methods: Changes in peripheral blood smears from 38 subjects were observed using peripheral live blood cell imaging (LBCI) with phase contrast microscopy. Observation of changes in properties of live blood was made and compared to placebo and baseline at five and 30 minutes after administration.

Results: Compared to baseline and control, the VMP35 formulation SK713 SLP technology effected positive changes in the blood. They were demonstrated by morphological, hematological and rheological changes observed five minutes from the intake and were sustained for at least 30 minutes post intake.

Conclusions: These observable changes showed that the SK713 SLP system can make a key contribution to increasing the potential benefits of dietary supplementation for those patients with compromised digestive processes. We encourage additional research on the effects of this novel nutraceutical formulation and delivery system.

Key Points:

➢ Digestive malfunction is a widespread malady (#1 in the U.S.)

➢ The purpose of this study was to evaluate the rate of absorption and effects on properties of the blood following the oral intake of a patent-pending SK713 SLP (Prodosome®) encapsulated VMP35 multiple vitamin, mineral and phytonutrient formulation.

➢ Compared to baseline and control, the VMP35 formulation SK713 SLP technology effected positive cellular structural, functional, and rate of flow changes in the blood five minutes from intake that were sustained for at least 30 minutes post intake.

➢ Red blood cells were larger and refilled with hemoglobin, demonstrating improved functional ability to carry oxygen and water.

➢ White blood cells (neutrophils) were larger and more abundant.

Prodovite Clinical Study